| Q34225956 | Altered CD8(+) T cell frequency and function in tuberculous lymphadenitis |
| Q38087272 | Antigen-specific CD8(+) T cells and protective immunity to tuberculosis |
| Q36400640 | CD40 ligand is not essential for induction of type 1 cytokine responses or protective immunity after primary or secondary infection with histoplasma capsulatum |
| Q36400834 | Characterization of human CD8+ T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells. |
| Q39473506 | Characterization of human Mycobacterium bovis bacille Calmette-Guérin-reactive CD8+ T cells. |
| Q34000680 | Clearance of Chlamydia trachomatis from the murine genital mucosa does not require perforin-mediated cytolysis or Fas-mediated apoptosis. |
| Q77419307 | Co-immunization with DNA vaccines expressing granulocyte-macrophage colony-stimulating factor and mycobacterial secreted proteins enhances T-cell immunity, but not protective efficacy against Mycobacterium tuberculosis |
| Q36399636 | Cytolytic CD8+ T cells recognizing CFP10 are recruited to the lung after Mycobacterium tuberculosis infection |
| Q37521603 | Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis |
| Q34001403 | Early emergence of CD8(+) T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice |
| Q33761193 | Fas (CD95)-dependent cell-mediated immunity to Listeria monocytogenes. |
| Q35784093 | Gamma interferon responses of CD4 and CD8 T-cell subsets are quantitatively different and independent of each other during pulmonary Mycobacterium bovis BCG infection |
| Q34000497 | Generation of CD8(+) T-cell responses to Mycobacterium bovis and mycobacterial antigen in experimental bovine tuberculosis |
| Q34001249 | Host defense against Mycobacterium avium does not have an absolute requirement for major histocompatibility complex class I-restricted T cells. |
| Q39473497 | Human CD8(+) T cells specific for Mycobacterium tuberculosis secreted antigens in tuberculosis patients and healthy BCG-vaccinated controls in The Gambia |
| Q35675454 | Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis |
| Q34006469 | Human natural killer cells mediate killing of intracellular Mycobacterium tuberculosis H37Rv via granule-independent mechanisms |
| Q34004633 | Identification and characterization of murine cytotoxic T cells that kill Mycobacterium tuberculosis |
| Q39831385 | Immunization with heat-killed Mycobacterium vaccae stimulates CD8+ cytotoxic T cells specific for macrophages infected with Mycobacterium tuberculosis. |
| Q39517388 | Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent |
| Q36313789 | Impaired expression of perforin and granulysin in CD8+ T cells at the site of infection in human chronic pulmonary tuberculosis |
| Q60156866 | Increased inducible apoptosis in CD4+ T lymphocytes during polymicrobial sepsis is mediated by Fas ligand and not endotoxin |
| Q34181985 | Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy |
| Q34120690 | Mycobacterial antigens exacerbate disease manifestations in Mycobacterium tuberculosis-infected mice |
| Q35097333 | Mycobacterium tuberculosis directs immunofocusing of CD8+ T cell responses despite vaccination |
| Q35099713 | Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity |
| Q35097409 | Mycobacterium tuberculosis-specific CD8+ T cells require perforin to kill target cells and provide protection in vivo |
| Q36071705 | Prime-boost vaccination with rBCG/rAd35 enhances CD8⁺ cytolytic T-cell responses in lesions from Mycobacterium tuberculosis-infected primates |
| Q39110327 | Programmed cell death as a defence against infection |
| Q33750714 | Protection against Mycobacterium tuberculosis infection by CD8+ T cells requires the production of gamma interferon. |
| Q35675358 | Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. |
| Q44080405 | Robust immune response elicited by a novel and unique Mycobacterium tuberculosis protein using an optimized DNA/protein heterologous prime/boost protocol |
| Q36367900 | Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis |
| Q73128904 | Thalidomide analogue CC1069 inhibits development of rat adjuvant arthritis |
| Q35545357 | The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms |
| Q34266438 | The many faces of host responses to tuberculosis |
| Q36376221 | The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice |
| Q36090400 | The tuberculous granuloma: an unsuccessful host defence mechanism providing a safety shelter for the bacteria? |
| Q34034191 | Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyprotein |
| Q33752344 | Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection |
| Q35894501 | Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta |